| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.49 | 0.09 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.4 | 0.2 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.32 | 0.01 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.31 | 0.06 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.3 | 0.05 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.3 | 0.04 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.29 | 0.08 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.28 | 0.08 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.27 | 0.08 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |